Mostrar el registro sencillo del ítem

dc.creatorAhmed N., Audebert H., Turc G., Cordonnier C., Christensen H., Sacco S., Sandset E.C., Ntaios G., Charidimou A., Toni D., Pristipino C., Köhrmann M., Kuramatsu J.B., Thomalla G., Mikulik R., Ford G.A., Martí-Fàbregas J., Fischer U., Thoren M., Lundström E., Rinkel G.J.E., Worp H.B.V.D., Matusevicius M., Tsivgoulis G., Milionis H., Rubiera M., Hart R., Moreira T., Lantz M., Sjöstrand C., Andersen G., Schellinger P., Kostulas K., Sunnerhagen K.S., Keselman B., Korompoki E., Purrucker J., Khatri P., Whiteley W., Berge E., Mazya M., Dippel D.W.J., Mustanoja S., Rasmussen M., Söderqvist Å.K., Escudero-Martínez I., Steiner T.en
dc.date.accessioned2023-01-31T07:30:34Z
dc.date.available2023-01-31T07:30:34Z
dc.date.issued2019
dc.identifier10.1177/2396987319863606
dc.identifier.issn23969873
dc.identifier.urihttp://hdl.handle.net/11615/70338
dc.description.abstractThe purpose of the European Stroke Organisation–Karolinska Stroke Update Conference is to provide updates on recent stroke therapy research and to give an opportunity for the participants to discuss how these results may be implemented into clinical routine. The meeting started 22 years ago as Karolinska Stroke Update, but since 2014 it is a joint conference with European Stroke Organisation. Importantly, it provides a platform for discussion on the European Stroke Organisation guidelines process and on recommendations to the European Stroke Organisation guidelines committee on specific topics. By this, it adds a direct influence from stroke professionals otherwise not involved in committees and work groups on the guideline procedure. The discussions at the conference may also inspire new guidelines when motivated. The topics raised at the meeting are selected by the scientific programme committee mainly based on recent important scientific publications. This year’s European Stroke Organisation–Karolinska Stroke Update Meeting was held in Stockholm on 11–13 November 2018. There were 11 scientific sessions discussed in the meeting including two short sessions. Each session except the short sessions produced a consensus statement (Full version with background, issues, conclusions and references are published as web-material and at www.eso-karolinska.org and http://eso-stroke.org) and recommendations which were prepared by a writing committee consisting of session chair(s), scientific secretary and speakers. These statements were presented to the 250 participants of the meeting. In the open meeting, general participants commented on the consensus statement and recommendations and the final document were adjusted based on the discussion from the general participants Recommendations (grade of evidence) were graded according to the 1998 Karolinska Stroke Update meeting with regard to the strength of evidence. Grade A Evidence: Strong support from randomised controlled trials and statistical reviews (at least one randomised controlled trial plus one statistical review). Grade B Evidence: Support from randomised controlled trials and statistical reviews (one randomised controlled trial or one statistical review). Grade C Evidence: No reasonable support from randomised controlled trials, recommendations based on small randomised and/or non-randomised controlled trials evidence. © European Stroke Organisation 2019.en
dc.language.isoenen
dc.sourceEuropean Stroke Journalen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85072047127&doi=10.1177%2f2396987319863606&partnerID=40&md5=e96c5cb1bde4771c44eb4ca7c293275b
dc.subjectalteplaseen
dc.subjectandexanet alfaen
dc.subjectanticoagulant agenten
dc.subjectantivitamin Ken
dc.subjectblood clotting factor 10a inhibitoren
dc.subjectdabigatranen
dc.subjectglyceryl trinitrateen
dc.subjecthydroxymethylglutaryl coenzyme A reductase inhibitoren
dc.subjectidarucizumaben
dc.subjectproprotein convertase 9en
dc.subjectprothrombinen
dc.subjecttranexamic aciden
dc.subjectvitamin K groupen
dc.subjectanticoagulationen
dc.subjectartery occlusionen
dc.subjectArticleen
dc.subjectblood clot lysisen
dc.subjectblood glucose monitoringen
dc.subjectbrain hemorrhageen
dc.subjectbrain ischemiaen
dc.subjectcerebrovascular accidenten
dc.subjectclinical outcomeen
dc.subjectcomputed tomographic angiographyen
dc.subjectcomputer assisted tomographyen
dc.subjectconsensus developmenten
dc.subjectdigital subtraction angiographyen
dc.subjectemergency careen
dc.subjectendovascular surgeryen
dc.subjectevidence based practiceen
dc.subjecthumanen
dc.subjecthypertensionen
dc.subjectinsulin treatmenten
dc.subjectischemic preconditioningen
dc.subjectlow density lipoprotein cholesterol levelen
dc.subjectmagnetic resonance venographyen
dc.subjectmechanical thrombectomyen
dc.subjectmobilizationen
dc.subjectnuclear magnetic resonance imagingen
dc.subjectoutcome assessmenten
dc.subjectoxygen supplyen
dc.subjectpatient selectionen
dc.subjectpercutaneous coronary interventionen
dc.subjectpoint of care testingen
dc.subjectpractice guidelineen
dc.subjectpriority journalen
dc.subjectpublicationen
dc.subjectrecanalizationen
dc.subjectsecondary preventionen
dc.subjectsubarachnoid hemorrhageen
dc.subjecttransesophageal echocardiographyen
dc.subjecttransthoracic echocardiographyen
dc.subjectSAGE Publications Ltden
dc.titleConsensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11–13 November 2018en
dc.typejournalArticleen


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem